Navigation Links
Orexigen Resubmits Contrave New Drug Application
Date:12/11/2013

SAN DIEGO, Dec. 11, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Company has resubmitted the Contrave® New Drug Application to the United States (U.S.) Food and Drug Administration (FDA). Investigational drug Contrave (naltrexone sustained release (SR) / bupropion SR) is being developed for weight loss and maintenance of weight loss.

The resubmission follows the November 25, 2013 announcement of the successful interim analysis of the Light Study, the Contrave cardiovascular outcomes trial (CVOT), which is being conducted under a Special Protocol Assessment with the FDA. In January 2011, Orexigen received a Complete Response Letter (CRL) from the FDA detailing a single approval deficiency—the need to conduct a clinical trial of sufficient size and duration to exclude excess risk of major adverse cardiovascular events. In less than three years, Orexigen negotiated with FDA a feasible CVOT design, enrolled the CVOT, and generated safety data responsive to the CRL.

"Resubmitting the Contrave NDA is an exciting moment for Orexigen," said Michael Narachi, CEO of Orexigen. "I am proud of our team and admire their determination to bring Contrave forward to help patients with obesity."

Narachi continued: "This resubmission sets in motion the first of four potential key catalysts in 2014. With the successful Light Study interim analysis, we are confident in the prospect for approvals next year in the United States and in Europe. If Contrave is approved, we look forward to a well-executed U.S. launch by Takeda. Additionally, we anticipate making progress next year in our discussions with potential partners for Contrave for territories outside North America.
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes
2. Orexigen Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
3. Orexigen Announces Successful Interim Analysis of Contrave Light Study
4. Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast
5. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
6. Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta
7. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
8. A Balanced Risk-Benefit Profile Will Propel Orexigen/Takedas Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
9. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
10. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
11. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 Sinovac Biotech Ltd. (NASDAQ: ... China , announced today that it has been ... ("Beijing CDC") to be a supplier of the seasonal influenza ... for 2014. The Beijing CDC plans to order ... vaccine this year from four domestic vaccine manufacturers for its ...
(Date:7/23/2014)... , Indien, July 23, 2014 /PRNewswire/ ... additional scope für Arbeiten für Sadara Chemical ... comprehensive Engineering Information System innerhalb des integrierten ... Dieser award of additional scope im Wert ... des zuvor abgeschlossenen Vertrags dar, dessen Wert ...
(Date:7/22/2014)... -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its ... on Thursday, July 31, 2014, after the close of U.S.-based ... officer, will host a conference call to review the results ... (PT). The press release and a live ... a link that is posted on the home page and ...
Breaking Medicine Technology:Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3
... speech today to the City Club of San Diego, John ... Lilly and Company (NYSE: LLY ), said that the ... vision for biopharmaceutical companies to "reinvent innovation" to make the ... and address unmet medical needs. Lechleiter,s remarks came the ...
... 30 Physicians at St. David,s South Austin Hospital ... Lead-extraction is a complicated procedure to remove leads, or ... or other implanted Cardiac Rhythm Management (CRM) devices. Recent ... a safe and effective way to remove cardiac leads ...
Cached Medicine Technology:Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Innovation' 2Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Innovation' 3St. David's South Austin Hospital Leading the Central Texas Region in Laser-Assisted Lead-Extraction Procedures 2St. David's South Austin Hospital Leading the Central Texas Region in Laser-Assisted Lead-Extraction Procedures 3
(Date:7/23/2014)... July 23, 2014 QueenBeeTickets.com is reducing the ... a coup for rock music fans who are still in ... buyers visit the site, they can use promo code “DISCOUNT” ... Here to view the inventory of discounted tickets at ... in August, September and October, with The Eagles concert tickets ...
(Date:7/23/2014)... ISI Telemanagement Solutions, Inc., a leading ... Speech Analytics, a new product as part of ... gives users the ability to uncover vital customer information ... as well as chat sessions and social media announcements. ... new, adding speech analytics on to a recording solution ...
(Date:7/23/2014)... July 23, 2014 According to the ... estate transactions throughout the region, the Northern Virginia ... June. Homes are selling quickly throughout the area, and ... the region. The Northern Virginia market includes the city ... counties. , The Northern Virginia region saw median sale ...
(Date:7/23/2014)... Online medical service provider MeMD has appointed Dr. ... Dr. Lorenzo joins the MeMD executive team with over 25 ... part of this remote treatment model, telemedicine. This is the ... medical school, that someday we could treat people across the ... and it hasn't been that long,” says Dr. Lorenzo. , ...
(Date:7/23/2014)... PartnerTech Inc. , a major systems ... Andreas von Uexkull to their facilities, June 6, 2014 ... Uexkull, a top trade official from the Embassy of ... to bring awareness and insight to the business community ... , As an expert on global economy, von ...
Breaking Medicine News(10 mins):Health News:History of The Eagles Tour Tickets: QueenBeeTickets.com Reduces Prices on Remaining Inventory of Concert Tickets for 2014 Shows 2Health News:ISI Telemanagement Solutions, Inc. Releases Infortel® Speech Analytics 2Health News:ISI Telemanagement Solutions, Inc. Releases Infortel® Speech Analytics 3Health News:Northern Virginia Real Estate Company Pasquali Realty Group Announces Median Sale Price Increased in the Region in June 2014 2Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 2Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 3Health News:Swedish Official Tours PartnerTech’s U.S. Facility 2Health News:Swedish Official Tours PartnerTech’s U.S. Facility 3
... ... acquisition of emergency department consulting company, Medical Strategies and Management Systems. This ... helps emergency departments implement needed solutions and transform into top performers. , ... (PRWEB) March ...
... and psychological function after traumatic brain injury is closely related ... of Deutsches rzteblatt International ( Dtsch Arztebl Int ... Cramon conclude that this is not the case. In ... is mostly caused by traffic accidents, falls, or blows to ...
... One in three South Asian, West Asian or Arab women ... say they have trouble accessing a doctor to address ... findings, from a new study by researchers at St. Michael,s ... finds this group and immigrant women and men are at ...
... The new ... a silver medal at the 2010 Axiom Business Book Awards. , ... (PRWEB) March 30, 2010 -- The new book “On Top Of Everything: ... 2010 Axiom Business Book Awards ., , , , ,The Axiom Business Book Awards, now in ...
... U.S. Apple Association announces ... ... consumers and the media, the U.S. Apple Association (USApple) has entered the world of social networking, ... fan page on Facebook and profile on twitter went live Monday, joining a number of other ...
... usually call the shots; doctors unclear in their explanations, study ... with cancer who are enrolled in clinical research trials, most ... research from their parents and doctors, a new report suggests. ... patients, ages 7 to 18, and found that more ...
Cached Medicine News:Health News:Emergency Excellence Acquires Medical Strategies and Management Systems LLC 2Health News:Emergency Excellence Acquires Medical Strategies and Management Systems LLC 3Health News:Minority women least likely to gain access to a doctor, study says 2Health News:"On Top Of Everything” Wins Silver at the 2010 Axiom Business Book Awards 2Health News:Get your Virtual ‘Apple a Day' 2Health News:Many Kids Not Fully Informed of Their Role in Cancer Studies 2
... Cauteries provide a broad selection of ... wide variety of ophthalmic procedures. Each ... complete with a safety cap to ... position when not in use, and ...
... Cauteries provide a broad selection of ... wide variety of ophthalmic procedures. Each ... complete with a safety cap to ... position when not in use, and ...
... B-VAT® PC visual acuity system allows you ... the B-VAT II. The system includes 10 ... sensitivity testing and animated characters. Random character ... has single letter, single line and multiple ...
... Light Probes provide the surgeon with an ... interface to be easily visualized through the ... effect and light scatter technique, the surgeon ... deposits, flap edge folds, corneal flap striae ...
Medicine Products: